Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

3.7K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
3.7K
Phase II Conjugation Reactions: Overview01:14

Phase II Conjugation Reactions: Overview

146
Conjugation, a key component of phase II biotransformation reactions, is a vital process in drug detoxification. It involves transferring endogenous substances like glucuronic acid, sulfate, and glycine to drugs or their metabolites formed in phase I reactions. These conjugation reactions, often catalyzed by specific enzymes, transform potentially harmful metabolites into inactive, water-soluble forms easily excreted in urine or bile. By enhancing polarity and eliminating pharmacological...
146

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Antibodies raised against a structurally defined Aβ oligomer mimic protect human iPSC neurons from Aβ toxicity at sub-stoichiometric concentrations.

PloS one·2025
Same author

Mini-αA-crystallin protects a client lens protein from catastrophic aggregation due to heat stress.

Protein science : a publication of the Protein Society·2025
Same author

A β-hairpin peptide derived from Aβ forms different oligomers in the crystal state and in aqueous solution.

Organic & biomolecular chemistry·2025
Same author

Potent Analogues of Clovibactin from Commercially Available Amino Acid Building Blocks.

The Journal of organic chemistry·2025
Same author

α-Methylation Enables the X-ray Crystallographic Observation of Oligomeric Assemblies Formed by a β-Hairpin Peptide Derived from Aβ.

The Journal of organic chemistry·2024
Same author

Teixobactin "Swapmers" with l Tail Stereochemistry Retain Antibiotic Activity.

The Journal of organic chemistry·2024
Same journal

A Ni-Mediated Cross-Coupling Approach to Deuterated <sup>18</sup>F- Fluoromethylated (Hetero)arenes.

Journal of the American Chemical Society·2026
Same journal

Efficient Light-Driven CO<sub>2</sub> Capture and Reversible Release Enabled by Metastable Photoacid-Decorated Metal-Organic Frameworks.

Journal of the American Chemical Society·2026
Same journal

In Situ Raman Spectroscopy Reveals the Dynamic Evolution and Ethanol Dependence of SEI Structure in Li-Mediated N<sub>2</sub> Reduction Reaction.

Journal of the American Chemical Society·2026
Same journal

Solvent Esterification and Stoichiometric Control in Ambient-Grown FAPbI<sub>3</sub> Single-Crystal Solar Cells.

Journal of the American Chemical Society·2026
Same journal

Unlocking Azulene Functionalization via Strain-Induced Azulyne Intermediates.

Journal of the American Chemical Society·2026
Same journal

An Oxazine-Locked Covalent Organic Framework by a Tandem Pinner/Schiff Base Reaction for Hydrogen Peroxide Photosynthesis.

Journal of the American Chemical Society·2026
See all related articles

Related Experiment Video

Updated: Apr 30, 2026

Intranasal Administration of Recombinant Influenza Vaccines in Chimeric Mouse Models to Study Mucosal Immunity
10:39

Intranasal Administration of Recombinant Influenza Vaccines in Chimeric Mouse Models to Study Mucosal Immunity

Published on: June 25, 2015

12.3K

Vancomycin-Teixobactin Conjugates.

Maria Sophia Teresa Lee Padilla1, James S Nowick1,2,3

  • 1Department of Chemistry, University of California, Irvine, Irvine, California 92697, United States.

Journal of the American Chemical Society
|February 14, 2025
PubMed
Summary
This summary is machine-generated.

Conjugating vancomycin to a teixobactin pharmacophore boosts its effectiveness against resistant bacteria. This novel approach enhances activity against challenging pathogens like MRSA and VRE.

More Related Videos

In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis
07:25

In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis

Published on: May 4, 2017

17.0K
Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens
13:47

Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens

Published on: May 19, 2020

3.0K

Related Experiment Videos

Last Updated: Apr 30, 2026

Intranasal Administration of Recombinant Influenza Vaccines in Chimeric Mouse Models to Study Mucosal Immunity
10:39

Intranasal Administration of Recombinant Influenza Vaccines in Chimeric Mouse Models to Study Mucosal Immunity

Published on: June 25, 2015

12.3K
In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis
07:25

In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis

Published on: May 4, 2017

17.0K
Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens
13:47

Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens

Published on: May 19, 2020

3.0K

Area of Science:

  • Medicinal Chemistry
  • Microbiology
  • Drug Discovery

Background:

  • Vancomycin is a critical last-resort antibiotic for drug-resistant infections.
  • Emergence of vancomycin-resistant strains, such as vancomycin-resistant Enterococci (VRE), necessitates new therapeutic strategies.

Purpose of the Study:

  • To investigate the enhancement of vancomycin's antibiotic activity through conjugation.
  • To develop novel conjugates effective against resistant Gram-positive pathogens.

Main Methods:

  • Conjugation of vancomycin to a modified teixobactin pharmacophore (residues 1-6 replaced with aromatic amide).
  • Evaluation of minimum inhibitory concentrations (MICs) against methicillin-resistant Staphylococcus aureus (MRSA), methicillin-susceptible Staphylococcus aureus (MSSA), and VRE.

Main Results:

  • Identified three vancomycin-teixobactin conjugates with significantly enhanced activity against MRSA and MSSA compared to individual components.
  • Demonstrated that these conjugates retain activity against VRE, even when individual components are ineffective.
  • The most potent conjugate exhibited MICs of 0.5 μg/mL against MRSA and 0.063-0.125 μg/mL against MSSA.

Conclusions:

  • Conjugation of vancomycin to a minimal teixobactin pharmacophore is a viable strategy to overcome antibiotic resistance.
  • This approach offers a promising avenue for developing new treatments against challenging Gram-positive bacterial infections.